Asston Pharmaceuticals Appoints New Auditors, Approves Remuneration Hike

Asston Pharmaceuticals Ltd announced a series of board resolutions passed on September 04, 2026. Key decisions include the appointment of M/s Yash A. Jain & Associates as Internal Auditors and M/s Panchal S K & Associates as Statutory Auditors. The board also approved the re-appointment of Mr. Ashish Narayan Sakalkar as Director retiring by rotation and proposed increases in remuneration for Mr. Sakalkar (Managing Director), Mrs. Saili Jayaram More (Whole-time Director and CEO), and Mr. Sachin Chandrakant Badakh (Non-Executive Director), subject to member approval. Additionally, the company approved the Board's Report for the 7th Annual Report, appointed a scrutinizer for the 7th Annual General Meeting (AGM), and set the AGM date for September 29, 2026, with September 22, 2026, as the cut-off date for e-voting.